Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

Haematologica. 2015 Dec;100(12):e508-10. doi: 10.3324/haematol.2015.128728. Epub 2015 Sep 4.
No abstract available

Keywords: allogeneic stem cell transplantation; myeloma; prognosis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Autografts
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Multiple Myeloma / mortality*
  • Multiple Myeloma / therapy*
  • Stem Cell Transplantation*
  • Survival Rate

Associated data

  • ISRCTN/ISRCTN06413384
  • NTR/NTR238